Disclosed positions

Estimated from their latest filings — positions may have changed since

$3.95M

combined est. value

Stock	Shares	Price	Value	Weight	As of
TBPHTheravance Biopharma, Inc.	232,457	$16.98	$3.95M	100%	2026-06-15

TBPH

Theravance Biopharma, Inc.

$3.95M

232,457 sh

All filings on record

Every Form 4 transaction we track for this filer

all 14buys 0sells 10

Stock	Transaction	Date	~6mo later
TBPHTheravance Biopharma, Inc.	Sell $109.1K · 6,657 sh	2026-06-15	—
TBPHTheravance Biopharma, Inc.	Sell $54.5K · 3,328 sh	2026-06-15	—
TBPHTheravance Biopharma, Inc.	Sell $54.6K · 3,329 sh	2026-06-15	—
TBPHTheravance Biopharma, Inc.	Tax $94.0K · 5,678 sh	2026-05-20	—
TBPHTheravance Biopharma, Inc.	Tax $273.8K · 13,929 sh	2026-02-20	—
TBPHTheravance Biopharma, Inc.	Sell $291.3K · 15,534 sh	2025-12-03	—
TBPHTheravance Biopharma, Inc.	Sell $145.6K · 7,766 sh	2025-12-03	—
TBPHTheravance Biopharma, Inc.	Sell $145.6K · 7,767 sh	2025-12-03	—
TBPHTheravance Biopharma, Inc.	Tax $162.2K · 9,060 sh	2025-11-20	—
TBPHTheravance Biopharma, Inc.	Tax $121.8K · 9,096 sh	2025-08-20	—
TBPHTheravance Biopharma, Inc.	Sell $45.6K · 4,000 sh	2025-07-14	—
TBPHTheravance Biopharma, Inc.	Sell $60.5K · 5,318 sh	2025-07-14	—
TBPHTheravance Biopharma, Inc.	Sell $7.8K · 682 sh	2025-07-14	—
TBPHTheravance Biopharma, Inc.	Sell $264.0K · 24,000 sh	2025-06-02	—

TBPHSell

2026-06-15 · Theravance Biopharma, Inc.

$109.1K

—

TBPHSell

2026-06-15 · Theravance Biopharma, Inc.

$54.5K

—

TBPHSell

2026-06-15 · Theravance Biopharma, Inc.

$54.6K

—

TBPHTax

2026-05-20 · Theravance Biopharma, Inc.

$94.0K

—

TBPHTax

2026-02-20 · Theravance Biopharma, Inc.

$273.8K

—

TBPHSell

2025-12-03 · Theravance Biopharma, Inc.

$291.3K

—

TBPHSell

2025-12-03 · Theravance Biopharma, Inc.

$145.6K

—

TBPHSell

2025-12-03 · Theravance Biopharma, Inc.

$145.6K

—

TBPHTax

2025-11-20 · Theravance Biopharma, Inc.

$162.2K

—

TBPHTax

2025-08-20 · Theravance Biopharma, Inc.

$121.8K

—

TBPHSell

2025-07-14 · Theravance Biopharma, Inc.

$45.6K

—

TBPHSell

2025-07-14 · Theravance Biopharma, Inc.

$60.5K

—

TBPHSell

2025-07-14 · Theravance Biopharma, Inc.

$7.8K

—

TBPHSell

2025-06-02 · Theravance Biopharma, Inc.

$264.0K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.